Literature DB >> 22550432

Skin cancer of the head and neck.

Yun-Hsuan Ouyang1.   

Abstract

The majority of skin cancers of the head and neck are nonmelanoma skin cancers (NMSC). Basal cell carcinoma and squamous cell carcinoma are the most frequent types of NMSC. Malignant melanoma is an aggressive neoplasm of skin, and the ideal adjuvant therapy has not yet been found, although various options for treatment of skin cancer are available to the patient and physician, allowing high cure rate and excellent functional and cosmetic outcomes. Sunscreen protection and early evaluation of suspicious areas remain the first line of defense against skin cancers.

Entities:  

Keywords:  Basal cell carcinoma; Mohs' micrographic surgery; melanoma; nonmelanoma skin cancer; squamous cell carcinoma

Year:  2010        PMID： 22550432      PMCID： PMC3324239          DOI： 10.1055/s-0030-1255329

Source DB:  PubMed          Journal:  Semin Plast Surg        ISSN： 1535-2188            Impact factor:   2.314


  34 in total

1.  Guidelines of care for primary cutaneous melanoma.

Authors:  A J Sober; T Y Chuang; M Duvic; E R Farmer; J M Grichnik; A C Halpern; V Ho; V Holloway; A F Hood; T M Johnson; B J Lowery
Journal:  J Am Acad Dermatol       Date:  2001-10       Impact factor: 11.527

2.  Mohs micrographic surgery for the treatment of primary cutaneous melanoma.

Authors:  J A Zitelli; C Brown; B H Hanusa
Journal:  J Am Acad Dermatol       Date:  1997-08       Impact factor: 11.527

Review 3.  Cutaneous malignancies and their management.

Authors:  J K Padgett; J D Hendrix
Journal:  Otolaryngol Clin North Am       Date:  2001-06       Impact factor: 3.346

Review 4.  Merkel cell carcinoma arising in the head and neck: optimizing therapy.

Authors:  B D Lawenda; J K Thiringer; R D Foss; P A Johnstone
Journal:  Am J Clin Oncol       Date:  2001-02       Impact factor: 2.339

Review 5.  Effects of solar radiation on the skin.

Authors:  R A Buzzell
Journal:  Otolaryngol Clin North Am       Date:  1993-02       Impact factor: 3.346

6.  The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas.

Authors:  L Edwards; S B Tucker; D Perednia; K A Smiles; E L Taylor; D J Tanner; E Peets
Journal:  Arch Dermatol       Date:  1990-08

Review 7.  Recognition and management of unusual cutaneous tumors.

Authors:  M D Brown
Journal:  Dermatol Clin       Date:  2000-07       Impact factor: 3.478

8.  Radiation therapy in skin cancer. A historical perspective and current applications.

Authors:  J N Halpern
Journal:  Dermatol Surg       Date:  1997-11       Impact factor: 3.398

Review 9.  Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.

Authors:  D E Rowe; R J Carroll; C L Day
Journal:  J Am Acad Dermatol       Date:  1992-06       Impact factor: 11.527

Review 10.  The role of adjuvant therapy in melanoma management.

Authors:  A Barth; D L Morton
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860
View more
  10 in total

Review 1.  Facial Skin Cancer Reconstruction.

Authors:  Jesse D Meaike; Ryan M Dickey; Elizabeth Killion; Erica L Bartlett; Rodger H Brown
Journal:  Semin Plast Surg       Date:  2016-08       Impact factor: 2.314

2.  Nasal skin reconstruction: Time to rethink the reconstructive ladder?

Authors:  Inge J Veldhuizen; Philip Brouwer; Abdullah Aleisa; Nicholas R Kurtansky; Stephen W Dusza; Kishwer S Nehal; Maarten M Hoogbergen; René R W J van der Hulst; Erica H Lee
Journal:  J Plast Reconstr Aesthet Surg       Date:  2021-11-14       Impact factor: 2.740

3.  Trends in Cancers of the Skin: Insights from a Three-year Observational Cohort in Manhattan Beach, California.

Authors:  Lawrence S Moy; Jacob M Hands; Paul K Shitabata
Journal:  J Clin Aesthet Dermatol       Date:  2022-01

4.  To see or not to see: Impact of viewing facial skin cancer defects prior to reconstruction.

Authors:  Inge J Veldhuizen; Erica H Lee; Nicholas R Kurtansky; Lucy J van Hensbergen; Stephen W Dusza; Marleen C Hölscher; René R W J van der Hulst; Maarten J Ottenhof; Andrea L Pusic; Maarten M Hoogbergen
Journal:  Arch Dermatol Res       Date:  2021-01-30       Impact factor: 3.017

5.  Frequency of Head and Neck Squamous Cell Carcinomas and Related Variables in Southern Iran (Ahvaz City): 10-Year Retrospective Study

Authors:  Sedigheh Bakhtiari; Hamed Mortazavi; Masoumeh Mehdipour; Nahal Jafarian; Nastaran Ranjbari; Somayeh Rahmani
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

6.  Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin.

Authors:  Roberto Campagna; Tiziana Bacchetti; Eleonora Salvolini; Valentina Pozzi; Elisa Molinelli; Valerio Brisigotti; Davide Sartini; Anna Campanati; Gianna Ferretti; Annamaria Offidani; Monica Emanuelli
Journal:  Antioxidants (Basel)       Date:  2020-12-07

7.  Decursinol Angelate Arrest Melanoma Cell Proliferation by Initiating Cell Death and Tumor Shrinkage via Induction of Apoptosis.

Authors:  Sukkum Ngullie Chang; Imran Khan; Chang Geon Kim; Seon Min Park; Dong Kyu Choi; Heejin Lee; Buyng Su Hwang; Sun Chul Kang; Jae Gyu Park
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

8.  The efficacy of a photolyase-based device on the cancerization field: a clinical and thermographic study.

Authors:  Luigi Laino; Fulvia Elia; Flora Desiderio; Alessandra Scarabello; Isabella Sperduti; Carlo Cota; Aldo DiCarlo
Journal:  J Exp Clin Cancer Res       Date:  2015-08-19

9.  Risk of malignant skin neoplasms in a cohort of workers occupationally exposed to ionizing radiation at low dose rates.

Authors:  Tamara V Azizova; Maria V Bannikova; Evgeniya S Grigoryeva; Valentina L Rybkina
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

10.  Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck.

Authors:  Mojgan Alaeddini; Shahroo Etemad-Moghadam
Journal:  Braz J Otorhinolaryngol       Date:  2020-09-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.